Key result
Cumulative metabolic indices linked to ~30% higher CVD odds per SD in early CKM syndrome.
Why the study?
The cumulative effects of TyG-derived metabolic indices and the role of intrinsic capacity in cardiovascular disease risk among early-stage CKM syndrome patients remain unclear.
Do cumulative average metabolic indices and baseline intrinsic capacity predict and mediate incident cardiovascular disease risk in middle-aged and older adults with CKM syndrome stages 0–3?
Cohort (n=3,832)
Yes
Do cumulative average metabolic indices and baseline intrinsic capacity predict and mediate incident cardiovascular disease risk in middle-aged and older adults with CKM syndrome stages 0–3?
Answers are grounded in this paper and cite their sources.
Integrating cumulative insulin resistance-adiposity indices with functional intrinsic capacity assessments modestly improves cardiovascular risk stratification and reveals a partial mediating role of functional reserve in early-stage CKM syndrome.
Early stages (0–3) of cardiovascular-kidney-metabolic (CKM) syndrome represent a critical window for cardiovascular disease (CVD) prevention. Triglyceride–glucose (TyG)-derived indices reflect insulin resistance and metabolic burden, but their cumulative effects and the role of intrinsic capacity (IC) remain unclear. In this prospective study from the China Health and Retirement Longitudinal Study (CHARLS), 3,832 adults with CKM stages 0–3 and without baseline CVD were included. Fourteen cumulative average metabolic indices were derived from repeated measurements. Multivariable logistic regression and restricted cubic spline models were used to evaluate associations and dose–response relationships, with false discovery rate (FDR) correction applied for multiple comparisons. Joint effects with IC, predictive performance (AUC, calibration, decision curve analysis, NRI, and IDI), and mediation effects were assessed. During a median follow-up of 4.0 years, 303 incident CVD cases (7.9%) occurred. Five indices (TyG-BMI, TyG-WHtR, TyG-CI, TyG-CVAI, and METS-IR) were significantly associated with higher odds of new-onset CVD after full adjustment and FDR correction (per SD OR range: 1.27–1.36), with approximately linear dose–response relationships. Lower IC was associated with higher CVD risk. Individual indices showed modest discrimination (AUC range: 0.580–0.604), and incorporating IC provided incremental predictive information (AUC up to 0.621, both NRI and IDI P < 0.01). IC partially mediated these associations, with modest mediation proportions (≈ 4%–7%). Cumulative metabolic burden is independently associated with CVD risk in early-stage CKM syndrome. IC showed joint associations and modest mediating effects and provided complementary information for CVD risk assessment. Integrating metabolic and functional assessments may enhance early risk stratification.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a cohort in Early-stage cardiovascular-kidney-metabolic (CKM) syndrome (stages 0-3) (n=3,832). Cumulative average metabolic indices (TyG-BMI, TyG-WHtR, TyG-CI, TyG-CVAI, and METS-IR) and intrinsic capacity (IC) vs. Lower levels/quartiles of cumulative average metabolic indices and higher intrinsic capacity was evaluated on Incident cardiovascular disease (self-reported first physician diagnosis or treatment of heart disease or stroke) (OR 1.297 per 1-SD increase in TyG-BMI (range 1.27-1.36 across 5 significant indices), 95% CI 1.132-1.485, p=<0.05 (FDR-adjusted)). Five cumulative average metabolic indices increased incident CVD odds in early CKM syndrome, with 4-7% mediation by intrinsic capacity.
Synapse has enriched 10 related papers. Consider them for comparative context: